PlayBeyondBio Program: Corona vaccine developer, AstraZeneca, selects two Israeli startups for investment
22.11.20|By PlayBeyondBio
Against the background of the global health crisis, the first cycle of the PlayBeyondBio project ended today (Tuesday) - a fast track program to transform Israeli startups in the field of digital health into groundbreaking international companies